Track Vyant Bio, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Vyant Bio, Inc. VYNT · Stock Open Vyant Bio, Inc. in new tab

0.1940 USD
Loading chart...

DCF valuation

Model fair value for Vyant Bio, Inc. (VYNT)
Result
Sign in to run the valuation for VYNT.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

Vyant Bio, Inc. Logo Vyant Bio, Inc. Analysis (VYNT)

United States Health Care Official Website Stock

Is Vyant Bio, Inc. a good investment? Vyant Bio, Inc. (VYNT) is currently trading at 0.1940 USD.

Investor FAQ

Does Vyant Bio, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Vyant Bio, Inc.?

Vyant Bio, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). Vyant Bio, Inc. has a collaboration agreement to discover drugs for the treatment of Parkinson's Disease. The company is based in Cherry Hill, New Jersey.

Exchange Ticker
NMS (United States) VYNT
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Oct. 25, 2019 0.03
Nov. 2, 2022 1:5
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion